Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)

Abroad (travel likely)RecruitingPHASE3

Conditions

Sleep Wake Disorders · Sleep Disorders, Circadian Rhythm · Chronobiology Disorders

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Vanda Investigational Site, Los Angeles, California, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Redwood City, California, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Aurora, Colorado, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Boston, Massachusetts, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, St Louis, Missouri, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, New Hyde Park, New York, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Cincinnati, Ohio, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Cleveland, Ohio, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Columbia, South Carolina, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, San Antonio, Texas, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Sherman, Texas, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Innsbruck, Austria

  • Vanda Investigational Site, Vienna, Austria

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Berlin, Germany

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Hamburg, Germany

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Marburg, Germany

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Schwerin, Germany

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400